Silvia Cristofanon
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network.
Journal: Nature communications
Published: October 29, 2015
Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis.
Journal: Cell death & disease
Published: December 17, 2013
Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes.
Journal: Cell death and differentiation
Published: December 23, 2012
ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells.
Journal: Cell death & disease
Published: November 30, 2012
The dual PI3K/mTOR inhibitor NVP-BEZ235 and chloroquine synergize to trigger apoptosis via mitochondrial-lysosomal cross-talk.
Journal: International journal of cancer
Published: April 23, 2012
Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process.
Journal: Cell death and differentiation
Published: February 21, 2012
Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
Journal: Oncogene
Published: January 24, 2012
RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex.
Journal: Oncogene
Published: December 02, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026